Opioid Use Disorder clinical trials
Showing 151–200 of 254 active trials. Describe your situation to see which ones you may be eligible for.
- Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
- NavSTAR Implementation Effectiveness Trial Across a Health System
- Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
- Resilience Among Individuals With Opioid Use Disorder
- Combined THC and CBD for OUD and Chronic Pain
- Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
- Effects of Dronabinol in Opioid Maintained Patients
- Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform
- An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)
- Opioid Drug Interaction Study
- Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department
- Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
- PRoducing Outcome Measures for OTP Quality Improvement
- Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment
- Methadone Patient Access to Collaborative Treatment
- Opioid Treatment and Peer Recovery Support
- Expanding Medication-Assisted Therapies in Central Asia
- Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department
- Testing MOUD Scale-Up
- Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
- Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
- Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
- The ENHANCE Project Toolkit
- Focused Ultrasound for the Complex Patient
- Opioids, Low Nicotine Cigarettes, and Chronic Pain
- Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
- Low-Intensity Focused Ultrasound and the Complex Patient
- Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
- Opioid/Benzodiazepine Polydrug Abuse: Aim 3
- Sleep Disordered Breathing With Opioid Use
- Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
- A Clinical Trial of Telehealth Treatment for Opioid Use Disorders
- Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2
- A Bundled Intervention to End Opioid Overdoses
- Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation
- Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine
- VK4-116 Phase I Study With Food-Effect
- Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
- Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
- Integrating MOUD in Nonmedical Community Settings (Better Together)
- Family-Focused Study to Support Medication for Opioid Use Disorder
- Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement
- Reentry Incentives and Support for Engagement With Contingency Management
- Dynamic Treatment Regimes for Opioid Use Disorder
- Psilocybin After Trauma Surgery for Pain
- Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
- NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.